Trial · NCT00723931
Adverse events38
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 38
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Pegintron/Pegintron Redipen Injection | 237 | 1,267 | 243 |
| other | Leukopenia | Blood and lymphatic system disorders | Pegintron/Pegintron Redipen Injection | 144 | 1,267 | 152 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Pegintron/Pegintron Redipen Injection | 81 | 1,267 | 84 |
| other | Dyspepsia | Gastrointestinal disorders | Pegintron/Pegintron Redipen Injection | 102 | 1,267 | 112 |
| other | Nausea | Gastrointestinal disorders | Pegintron/Pegintron Redipen Injection | 69 | 1,267 | 76 |
| other | Asthenia | General disorders | Pegintron/Pegintron Redipen Injection | 80 | 1,267 | 87 |
| other | Fatigue | General disorders | Pegintron/Pegintron Redipen Injection | 70 | 1,267 | 76 |
| other | Pyrexia | General disorders | Pegintron/Pegintron Redipen Injection | 71 | 1,267 | 86 |
| other | White Blood Cell Count Decreased | Investigations | Pegintron/Pegintron Redipen Injection | 97 | 1,267 | 107 |
| other | Decreased Appetite | Metabolism and nutrition disorders | Pegintron/Pegintron Redipen Injection | 124 | 1,267 | 137 |
| other | Myalgia | Musculoskeletal and connective tissue disorders | Pegintron/Pegintron Redipen Injection | 227 | 1,267 | 275 |
| other | Headache | Nervous system disorders | Pegintron/Pegintron Redipen Injection | 226 | 1,267 | 288 |
| other | Insomnia | Psychiatric disorders | Pegintron/Pegintron Redipen Injection | 82 | 1,267 | 87 |
| other | Alopecia | Skin and subcutaneous tissue disorders | Pegintron/Pegintron Redipen Injection | 82 | 1,267 | 84 |
| other | Pruritus | Skin and subcutaneous tissue disorders | Pegintron/Pegintron Redipen Injection | 182 | 1,267 | 198 |
| other | Rash | Skin and subcutaneous tissue disorders | Pegintron/Pegintron Redipen Injection | 70 | 1,267 | 77 |
| serious | Anaemia | Blood and lymphatic system disorders | Pegintron/Pegintron Redipen Injection | 1 | 1,267 | 1 |
| serious | Atrial Fibrillation | Cardiac disorders | Pegintron/Pegintron Redipen Injection | 1 | 1,267 | 1 |
| serious | Cardiac Failure | Cardiac disorders | Pegintron/Pegintron Redipen Injection | 1 | 1,267 | 1 |
| serious | Haemorrhoids | Gastrointestinal disorders | Pegintron/Pegintron Redipen Injection | 1 | 1,267 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00723931/events